PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.560.02 (-0.36%)
5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.46%
Positive revenue growth while STERV.HE is negative. John Neff might see a notable competitive edge here.
-41.81%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
14800.00%
EBIT growth above 1.5x STERV.HE's 144.48%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
14800.00%
Operating income growth above 1.5x STERV.HE's 144.48%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
445.83%
Net income growth above 1.5x STERV.HE's 129.62%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
444.12%
EPS growth above 1.5x STERV.HE's 130.56%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
444.12%
Diluted EPS growth above 1.5x STERV.HE's 130.56%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.13%
Share reduction while STERV.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.13%
Reduced diluted shares while STERV.HE is at 0.14%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-106.36%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-150.08%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-0.63%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-1.75%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-1.70%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
57.19%
10Y OCF/share CAGR under 50% of STERV.HE's 207.45%. Michael Burry would worry about a persistent underperformance in cash creation.
-121.47%
Negative 5Y OCF/share CAGR while STERV.HE is at 66.12%. Joel Greenblatt would question the firm’s operational model or cost structure.
-147.18%
Negative 3Y OCF/share CAGR while STERV.HE stands at 56.06%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-45.61%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-78.25%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-79.10%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
109.02%
10Y equity/share CAGR in line with STERV.HE's 103.76%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
36.19%
5Y equity/share CAGR at 50-75% of STERV.HE's 65.14%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
20.75%
3Y equity/share CAGR at 75-90% of STERV.HE's 23.67%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
17.70%
Our AR growth while STERV.HE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
11.16%
Inventory growth well above STERV.HE's 4.60%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.21%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-7.35%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
0.78%
We have some new debt while STERV.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-7.04%
We cut SG&A while STERV.HE invests at 59.60%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.